HHS

Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 47.13 M41.56 M38.63 M39.52 M39.86 M 159.57 M Gross profit 47.13 M41.56 M38.63 M39.52 M39.86 M 159.57 M Operating expenses 20.52 M19.9 M17.94 M16.87 M17.39 M 72.11 M Selling/general/admin expenses 5.73 M5.84 M5.54 M5.15 M5.68 M 22.21 M Research & development ————— — Operating income -1.55 M-40 K34 K509 K-117 K 386 K Non-Operating Income, Total -311 K-567 K-447 K-190 K-190 K -1.39 M Interest expense, net of interest capitalized 14 K15 K14 K13 K13 K 55 K Non-Operating Income, excl. Interest Expenses 618 K-68 K-75 K-97 K-63 K -303 K Unusual income/expense -943 K-514 K-386 K-106 K-140 K -1.15 M Pretax income -1.86 M-607 K-413 K319 K-307 K -1.01 M Equity in earnings ————— — Taxes 570 K-215 K-78 K2.6 M-2.51 M -197 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -2.43 M-392 K-335 K-2.29 M2.2 M -811 K Discontinued operations ————— — Net income -2.43 M-392 K-335 K-2.29 M2.2 M -811 K Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -2.43 M-392 K-335 K-2.29 M2.2 M -811 K Basic earnings per share (Basic EPS) -0.31-0.05-0.05-0.310.3 -0.11 Diluted earnings per share (Diluted EPS) -0.31-0.05-0.05-0.310.3 -0.11 Average basic shares outstanding 7.29 M7.36 M7.38 M7.42 M7.39 M 29.55 M Diluted shares outstanding 7.29 M7.36 M7.38 M7.42 M7.39 M 29.55 M EBITDA -275 K1.02 M1.1 M1.73 M1.01 M 4.86 M EBIT -1.55 M-40 K34 K509 K-117 K 386 K Cost of revenue 00000 0 Other cost of goods sold 00000 0 Depreciation & amortization (cash flow) 1.28 M1.06 M1.06 M1.22 M1.13 M 4.47 M